Publication & Citation Trends
Most Cited Works
Publications
11 total
Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection OA
Cited by 14
Semantic Scholar
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides OA
Cited by 137
OpenAlex
Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines. OA
Cited by 11
Semantic Scholar
Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration PDF
Cited by 105
OpenAlex
Targeting KLF1 for the Treatment of Sickle Cell Disease Using Antisense Oligonucleotides
Cited by 1
OpenAlex
Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice. OA
Cited by 74
Semantic Scholar
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease OA
Cited by 21
Semantic Scholar
Research Topics
Hemoglobinopathies and Related Disorders
(3)
Epigenetics and DNA Methylation
(2)
DNA and Nucleic Acid Chemistry
(2)
RNA Research and Splicing
(2)
Kruppel-like factors research
(2)
Frequent Co-Authors
Affiliations
Ionis Pharmaceuticals (United States)